Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis Kui LiMasaki MandaiIkuo Konishi Original Article 13 September 2008 Pages: 641 - 652
HER-2/neu mediated down-regulation of MHC class I antigen processing prevents CTL-mediated tumor recognition upon DNA vaccination in HLA-A2 transgenic mice Simona VertuaniChiara TriulziRolf Kiessling Original Article 27 September 2008 Pages: 653 - 664
The immunodominant HLA-A2-restricted MART-1 epitope is not presented on the surface of many melanoma cell lines Rikke Bæk SørensenNiels JunkerMads Hald Andersen Original Article 01 October 2008 Pages: 665 - 675
Enhancement of superantigen activity and antitumor response of staphylococcal enterotoxin C2 by site-directed mutagenesis Xiaogang WangMingkai XuChenggang Zhang Original Article 26 September 2008 Pages: 677 - 686
Regulation of arginase I activity and expression by both PD-1 and CTLA-4 on the myeloid-derived suppressor cells Yu LiuYinyan YuRongcun Yang Original Article 01 October 2008 Pages: 687 - 697
Immunosensitization with a Bcl-2 small molecule inhibitor Jonathan BegleyDan D. VoAntoni Ribas Original Article 20 September 2008 Pages: 699 - 708
Characterization of MHC class-I restricted TCRαβ+ CD4− CD8− double negative T cells recognizing the gp100 antigen from a melanoma patient after gp100 vaccination Simon VoelklTamson V. MooreKarin Fischer Original Article 03 October 2008 Pages: 709 - 718
Relationship between CD8-dependent antigen recognition, T cell functional avidity, and tumor cell recognition Tamson V. MooreGretchen E. LyonsMichael I. Nishimura Original Article 03 October 2008 Pages: 719 - 728
Effect of invariant chain on major histocompatibility complex class I molecule expression and stability on human breast tumor cell lines Xuede LinXiaojian WangJoyce C. Solheim Original Article 01 October 2008 Pages: 729 - 736
Low-dose radiation enhances therapeutic HPV DNA vaccination in tumor-bearing hosts Chih-Wen TsengCornelia TrimbleT.-C. Wu Original Article 25 September 2008 Pages: 737 - 748
Paradoxical concentration effect of a homodimerizing antibody against a human non-small cell lung cancer cell line Heinz KohlerAnn Jay Bryan Original Article 27 September 2008 Pages: 749 - 758
Her-2 DNA versus cell vaccine: immunogenicity and anti-tumor activity Paula J. WhittingtonOlga Radkevich-BrownWei-Zen Wei Original Article 03 October 2008 Pages: 759 - 767
Salmonella typhimurium engineered to produce CCL21 inhibit tumor growth Markus LoefflerGaelle Le’NegrateJohn C. Reed Short Communication 17 July 2008 Pages: 769 - 775
Report on the sixth annual meeting of the Association for Immunotherapy of Cancer (CIMT), May 15 and 16, 2008 in Mainz, Germany Marij J. P. WeltersNadine van MontfoortCedrik M. Britten Meeting Report 04 November 2008 Pages: 777 - 787
Fit for purpose? A case study: validation of immunological endpoint assays for the detection of cellular and humoral responses to anti-tumour DNA fusion vaccines Ann ManderFerdousi ChowdhuryChristian H. Ottensmeier Focussed Research Review 10 December 2008 Pages: 789 - 800
TNK cells (NKG2D+ CD8+ or CD4+ T lymphocytes) in the control of human tumors Cristina MaccalliSamantha ScaramuzzaGiorgio Parmiani Focussed Research Review 17 December 2008 Pages: 801 - 808
TCR transgenes and transgene cassettes for TCR gene therapy: status in 2008 Wolfgang UckertTon N. M. Schumacher Focussed Research Review 03 February 2009 Pages: 809 - 822
Ipilimumab: controversies in its development, utility and autoimmune adverse events Jeffrey Weber Focussed Research Review 06 February 2009 Pages: 823 - 830
